Cellular mechanisms of tissue fibrosis. 5. Novel insights into liver fibrosis (Q27021577)

S. Lotersztajn

series ordinal

2

1 reference

language of work or name

1 reference

15 October 2013

1 reference

American Journal of Physiology - Cell Physiology

published in

1 reference

volume

305

1 reference

issue

8

1 reference

page(s)

C789-99

1 reference

PPARalpha expression protects male mice from high fat-induced nonalcoholic fatty liver

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00230.2013

Inhibition of hepatocyte autophagy increases tumor necrosis factor-dependent liver injury by promoting caspase-8 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00230.2013

CX3CL1-CX3CR1 interaction prevents carbon tetrachloride-induced liver inflammation and fibrosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00230.2013

Allosteric inhibition of lysyl oxidase–like-2 impedes the development of a pathologic microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00230.2013

Macrophage-derived Wnt opposes Notch signaling to specify hepatic progenitor cell fate in chronic liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00230.2013

Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00230.2013

Liver fatty acid binding protein (L-Fabp) modulates murine stellate cell activation and diet-induced nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00230.2013

Hedgehog controls hepatic stellate cell fate by regulating metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00230.2013

C-C motif chemokine receptor 9 positive macrophages activate hepatic stellate cells and promote liver fibrosis in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00230.2013

Hepatic myofibroblasts promote the progression of human cholangiocarcinoma through activation of epidermal growth factor receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00230.2013

Hepatocyte-stellate cell cross-talk in the liver engenders a permissive inflammatory microenvironment that drives progression in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00230.2013

Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00230.2013

Stimulating healthy tissue regeneration by targeting the 5-HT₂B receptor in chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00230.2013

Reversibility of hepatic fibrosis in treated genetic hemochromatosis: a study of 36 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00230.2013

A significant proportion of myofibroblasts are of bone marrow origin in human liver fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00230.2013

Natural killer and natural killer T cells in liver fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00230.2013

History, heterogeneity, developmental biology, and functions of quiescent hepatic stellate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00230.2013

Cannabinoid receptor 2 counteracts interleukin-17-induced immune and fibrogenic responses in mouse liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00230.2013

Dendritic cells limit fibroinflammatory injury in nonalcoholic steatohepatitis in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00230.2013

Pathogenesis of liver fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00230.2013

Autophagy releases lipid that promotes fibrogenesis by activated hepatic stellate cells in mice and in human tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00230.2013

Hepatic macrophage migration and differentiation critical for liver fibrosis is mediated by the chemokine receptor C-C motif chemokine receptor 8 in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00230.2013

Daily cannabis smoking as a risk factor for progression of fibrosis in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00230.2013

Daily cannabis use: a novel risk factor of steatosis severity in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00230.2013

Negligible contribution of bone marrow-derived cells to collagen production during hepatic fibrogenesis in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00230.2013

Regulation of wound healing and organ fibrosis by toll-like receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00230.2013

Suppression of macrophage infiltration inhibits activation of hepatic stellate cells and liver fibrogenesis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00230.2013

Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00230.2013

Extracellular matrix degradation in liver fibrosis: Biochemistry and regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00230.2013

Protection from liver fibrosis by a peroxisome proliferator-activated receptor δ agonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00230.2013

Paracrine activation of hepatic CB1 receptors by stellate cell-derived endocannabinoids mediates alcoholic fatty liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00230.2013

Apoptotic body engulfment by hepatic stellate cells promotes their survival by the JAK/STAT and Akt/NF-kappaB-dependent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00230.2013

Dendritic cell regulation of carbon tetrachloride-induced murine liver fibrosis regression

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00230.2013

Antifibrogenic role of the cannabinoid receptor CB2 in the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00230.2013

The fractalkine receptor CX₃CR1 protects against liver fibrosis by controlling differentiation and survival of infiltrating hepatic monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00230.2013

Obstructive jaundice expands intrahepatic regulatory T cells, which impair liver T lymphocyte function but modulate liver cholestasis and fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00230.2013

Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00230.2013

Bone marrow-derived fibrocytes participate in pathogenesis of liver fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00230.2013

Rat liver myofibroblasts and hepatic stellate cells: different cell populations of the fibroblast lineage with fibrogenic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00230.2013

Interleukin-22 induces hepatic stellate cell senescence and restricts liver fibrosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00230.2013

Senescence of activated stellate cells limits liver fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00230.2013

Inhibitory effects of microRNA 19b in hepatic stellate cell-mediated fibrogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00230.2013

The interleukin-17 pathway is involved in human alcoholic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00230.2013

Monocyte subsets in human liver disease show distinct phenotypic and functional characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00230.2013

IL-13 induces connective tissue growth factor in rat hepatic stellate cells via TGF-β-independent Smad signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00230.2013

Hepatic fibrosis: molecular mechanisms and drug targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00230.2013

Non-cell-autonomous tumor suppression by p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00230.2013

The endocannabinoid system as a key mediator during liver diseases: new insights and therapeutic openings

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00230.2013

Cannabinoid signaling and liver therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00230.2013

Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00230.2013

Pathophysiology of NASH: perspectives for a targeted treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00230.2013

Cultured human liver fat-storing cells produce monocyte chemotactic protein-1. Regulation by proinflammatory cytokines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00230.2013

Interleukin-17 signaling in inflammatory, Kupffer cells, and hepatic stellate cells exacerbates liver fibrosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00230.2013

Dual role of CCR2 in the constitution and the resolution of liver fibrosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00230.2013

Hyperactivation of anandamide synthesis and regulation of cell-cycle progression via cannabinoid type 1 (CB1) receptors in the regenerating liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00230.2013

Proangiogenic cytokines as hypoxia-dependent factors stimulating migration of human hepatic stellate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00230.2013

Attenuated liver fibrosis in the absence of B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00230.2013

Angiotensin II activates I kappaB kinase phosphorylation of RelA at Ser 536 to promote myofibroblast survival and liver fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00230.2013

MicroRNA-221/222 upregulation indicates the activation of stellate cells and the progression of liver fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00230.2013

Hepatic stellate cells require a stiff environment for myofibroblastic differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00230.2013

Tissue transglutaminase does not affect fibrotic matrix stability or regression of liver fibrosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00230.2013

Hepatic macrophages but not dendritic cells contribute to liver fibrosis by promoting the survival of activated hepatic stellate cells in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00230.2013

Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00230.2013

Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00230.2013

Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00230.2013

Hypoxia: A Link between Fibrogenesis, Angiogenesis, and Carcinogenesis in Liver Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00230.2013

Expression of insulin-like growth factor I by activated hepatic stellate cells reduces fibrogenesis and enhances regeneration after liver injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00230.2013

Evolving therapies for liver fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00230.2013

TLR4 enhances TGF-beta signaling and hepatic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00230.2013

Adipogenic transcriptional regulation of hepatic stellate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00230.2013

Hepatoprotective effects of the dual peroxisome proliferator-activated receptor alpha/delta agonist, GFT505, in rodent models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00230.2013

Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00230.2013

IL-17A plays a critical role in the pathogenesis of liver fibrosis through hepatic stellate cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00230.2013

Hepatic stellate cells secrete angiopoietin 1 that induces angiogenesis in liver fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00230.2013

Hepatocytes do not undergo epithelial-mesenchymal transition in liver fibrosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00230.2013

Beneficial paracrine effects of cannabinoid receptor 2 on liver injury and regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00230.2013

Deactivation of hepatic stellate cells during liver fibrosis resolution in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00230.2013

Epigenetic cell fate regulation of hepatic stellate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00230.2013

Hepatocyte growth factor gene therapy of liver cirrhosis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00230.2013

Ito cells are liver-resident antigen-presenting cells for activating T cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00230.2013

Liver cell-derived microparticles activate hedgehog signaling and alter gene expression in hepatic endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00230.2013

Mechanisms of fibrosis: therapeutic translation for fibrotic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00230.2013

Role of differentiation of liver sinusoidal endothelial cells in progression and regression of hepatic fibrosis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00230.2013

Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00230.2013

Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00230.2013

Multigenerational epigenetic adaptation of the hepatic wound-healing response

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00230.2013

Increased toxin-induced liver injury and fibrosis in interleukin-6-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPCELL.00230.2013